ICON plc has entered into a multi-year collaboration with Anthropic to integrate Anthropic's AI, Claude, into the clinical trial process. ICON, a global contract research organization, supports pharmaceutical companies by managing their clinical trials. As of June, the Dublin-based company employed around 40,200 people across 99 locations in 55 countries. Financial details of the partnership were not disclosed.
Federal health officials have organized private meetings with technology companies, researchers, and lobbyists to encourage greater adoption of clinical artificial intelligence in healthcare settings.
CareCloud, a major player in health technology managing sensitive patient information, has confirmed that hackers accessed one of its secured health data repositories.
The U.S. Federal Trade Commission has accused Hims & Hers, a company that provides prescriptions for sexual wellness and mental health, of using website trackers to share sensitive patient information with advertisers Meta and Snap.
NHS England has acknowledged an error in its data-protection paperwork that failed to fully disclose access rights to patient information. Contrary to earlier statements, staff at Palantir, the US-based data analytics company, are able to view identifiable patient data within the Federated Data Platform system. This clarification was provided following a request from the National Data Guardian, highlighting concerns about transparency in handling sensitive medical records.
Boston Scientific has revealed plans to reduce its workforce in Ireland, shortly after unveiling a $75 million expansion project in Galway. This move highlights a complex phase for the company balancing growth investments with operational adjustments.
Whether you operate a medical practice or a law firm, getting recognized by AI search engines hinges on three key strategies. Surprisingly, most businesses fail to implement any of these crucial steps.
CoreMap secured $37 million in an oversubscribed Series C funding round, with Medtronic as a key investor. This capital injection will support the development of advanced, data-driven tools aimed at improving the precision of atrial fibrillation ablation procedures.
Medical educators encourage proficiency with AI scribes for future doctors but express concern about the impact of relying on AI for clinical documentation on educational outcomes.
Leaders of the Federation of State Medical Boards share their perspectives on the emerging issue of whether artificial intelligence should be licensed to practice medicine. They explore the implications and challenges involved in governing AI within medical practice.
